Research & Science
EECP Research & Science
EECP is not a fringe therapy. It has been studied for decades, with landmark randomized trials published in leading cardiology journals. This library organizes that evidence by topic, with every entry linked to the primary source so you can judge it yourself.
Cardiovascular Health
EECP has its deepest evidence in cardiovascular care, led by the foundational MUST-EECP trial.
MUST-EECP Trial (Arora et al.)
Journal of the American College of Cardiology, 1999
A randomized, sham-controlled trial of 139 patients with stable angina found significant reductions in anginal episodes and nitroglycerin use, plus increased time to exercise-induced ST-segment depression. More than 70% of treated patients improved functional status.
Read the JACC editorial archiveCMS Coverage Determination
Centers for Medicare & Medicaid Services, National Coverage Analysis
CMS reviewed the EECP evidence base for refractory angina and issued a National Coverage Determination that defines when External Counterpulsation therapy is covered, a landmark in regulatory acceptance of the therapy.
Read the CMS coverage analysisCirculation & Vascular Function
Mechanistic studies examine how EECP affects the blood vessels themselves, not just symptoms.
Braith et al., Flow-Mediated Dilation Study
Circulation, 2010 (American Heart Association)
In a randomized sham-controlled study of 42 patients with chronic angina, EECP significantly improved brachial and femoral artery flow-mediated dilation, a measure of endothelial function, and reduced angina classification by 62% versus 0% in the sham group.
Read the Circulation studyExercise Capacity
Several trials measured what matters most to patients: how much more they can do.
PEECH Trial (Feldman et al.)
Journal of the American College of Cardiology, 2006
A randomized trial of 187 patients with mild-to-moderate heart failure found that at six months, 35% of EECP patients versus 25% of controls increased exercise time by 60 seconds or more, with improved quality of life and NYHA class.
Read the PEECH trial on PubMedAngina With Nonobstructive Coronary Artery Disease
American Journal of Cardiology, 2023
A 2023 study reported improvements in Canadian Cardiovascular Society angina class, six-minute walk distance and exercise tolerance in patients with angina and nonobstructive coronary artery disease treated with EECP.
Read the AJC 2023 studyEECP Safety
The safety of EECP is supported by decades of clinical use and systematic reviews.
Health Technology Assessment Systematic Review
National Institute for Health Research, UK (PubMed), 2009
This systematic review and economic analysis of EECP for stable angina and heart failure consolidated the clinical evidence base, including the MUST-EECP trial as the foundational randomized evidence supporting effectiveness.
Read the systematic reviewPerformance & Recovery
Circulation support is increasingly part of recovery programs for active adults and athletes.
Updated Meta-Analysis (2026)
Biomedicines (MDPI), systematic review and meta-analysis
A recent meta-analysis of EECP versus standard medical therapy for chronic refractory angina found a significant reduction in angina severity, while noting heterogeneity across studies and calling for further controlled research.
Read the 2026 meta-analysisGeneral Wellness
Beyond specific conditions, circulation sits at the heart of energy, recovery and healthy aging.
How to Use This Library
A practical note from the Thrive team
This library is organized by topic so you can judge the evidence yourself. Summaries are written for non-experts, and every study links directly to the primary source. Research context changes over time, so always combine what you read with your doctor's guidance.
See our full Research & Resources hubHow We Read This Evidence
These summaries are written for people who are not medical researchers. We describe what a study found without exaggeration: EECP "may support" or "is associated with" certain outcomes, because single studies prove little on their own. Always interpret research with your own doctor, who knows your full health picture. The official editorial guidance for EECP use in the United States comes from the FDA clearance and CMS coverage policy, not from this website.
Is EECP supported by research?
Yes. EECP has one of the stronger evidence bases among non-invasive circulation therapies, including the MUST-EECP randomized trial, the PEECH heart failure trial and mechanistic studies of vascular function published in leading cardiology journals.
What did the MUST-EECP trial find?
MUST-EECP was a double-blinded, sham-controlled trial of 139 patients with stable angina. It found significant reductions in anginal episodes and nitroglycerin use and improved exercise tolerance, and more than 70% of treated patients reported improved functional status.
Is EECP safe?
EECP is a non-invasive therapy with decades of clinical use and a body of safety evidence. Like any medical treatment, it is not appropriate for everyone, which is why an evaluation with a qualified professional should always come first.
Where can I read the primary research?
Every entry in our research library links directly to the primary study or the publishing organization, including the Journal of the American College of Cardiology, Circulation, PubMed and CMS. We summarize, but you can always read the source.
Start Here
Have Questions About EECP?
Book a free consultation to discuss EECP with our experienced team, review the research together and find out whether it may be a fit for your goals.
Visit the Clinic
A Convenient Draper Location
Thrive EECP
1111 East Draper Parkway
Draper, UT 84020
By appointment. Call ahead and we will find a time that works for you.
Easily reached from Sandy, South Jordan, Riverton, Herriman, Cottonwood Heights, Midvale, Murray, Lehi, Alpine, Highland and American Fork, along with other South Salt Lake Valley and northern Utah County communities.
Get Directions